Dahu Qi
No. 7 Weiwu Road
Zhengzhou, China
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
circ_0002970 promotes fibroblast-like synoviocytes invasion and the inflammatory response through Hippo/YAP signaling to induce CTGF/CCN1 expression in rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: December 20, 2024
Epidermal stem cell derived exosomes-induced dedifferentiation of myofibroblasts inhibits scarring via the miR-203a-3p/PIK3CA axis.
Journal: Journal of nanobiotechnology
Published: October 25, 2024
Combination of cobalt, chromium and titanium nanoparticles increases cytotoxicity in vitro and pro-inflammatory cytokines in vivo.
Journal: Journal of orthopaedic translation
Published: May 22, 2022
3D printed magnesium-doped β-TCP gyroid scaffold with osteogenesis, angiogenesis, immunomodulation properties and bone regeneration capability in vivo.
Journal: Biomaterials advances
Published: December 13, 2021
Three-dimensional printing of gyroid-structured composite bioceramic scaffolds with tuneable degradability.
Journal: Biomaterials advances
Published: August 18, 2021
Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Promotes Inflammation and Accelerates Osteoarthritis by Activating β-Catenin.
Journal: Frontiers in cell and developmental biology
Published: December 26, 2020
Inhibiting Monoacylglycerol Lipase Suppresses RANKL-Induced Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone Loss.
Journal: Frontiers in cell and developmental biology
Published: December 14, 2020
Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss.
Journal: Frontiers in pharmacology
Published: October 25, 2020
Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 30, 2019
NR1D1 modulates synovial inflammation and bone destruction in rheumatoid arthritis.
Journal: Cell death & disease
Published: September 28, 2019
Hesperetin suppresses RANKL-induced osteoclastogenesis and ameliorates lipopolysaccharide-induced bone loss.
Journal: Journal of cellular physiology
Published: September 01, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026